vaccine safety – Page 5 – Communicable Diseases Research

Shooting at a Moving Target—Effectiveness and Emerging Challenges for SARS-CoV-2 Vaccine Development

Review

Published on 2021-09-222022-10-28
Journal: Vaccines [Category] COVID-19,

[키워드] accelerate addressed adverse effects applied approval Breakthrough infection challenge clinical evaluation Compliance COVID-19 development Effectiveness Healthcare systems heterologous vaccination highlight Immune escape immunization implementation IMPROVE infected individual Infection Isolation Long COVID Mask measure mRNA vaccine normality Occurrence pandemic pathway positive powerful tool Prevent PROTECT restrict Safe SARS-CoV-2 SARS-CoV-2 pandemic SARS-CoV-2 vaccine SARS-CoV-2 vaccines second generation vaccines severe COVID-19 Shooting Side effect social distancing Transmission Vaccination strategy Vaccine Vaccine development vaccine effectiveness vaccine safety Vaccines variants Variation Viral antigen virus transmission virus variant virus variants
[DOI] 10.3390/vaccines9101052 PMC 바로가기 [Article Type] Review

Why are we vaccinating children against COVID-19?

COVID-19 Pandemic: Health impact and Novel research

Published on 2021-09-142022-10-29
Journal: Toxicology Reports [Category] COVID-19,

[키워드] Abstract adverse events age Analysis Biomarker changes in children clinical clinical trial Comorbidities COVID-19 death decrease Diseases Effect elevated FIVE group inoculation MOST mRNA vaccines normalized occur predictive power predisposition reported risk of death SARS-CoV-2 total population Trial vaccine safety Viral vector vaccines
[DOI] 10.1016/j.toxrep.2021.08.010 PMC 바로가기 [Article Type] COVID-19 Pandemic: Health impact and Novel research

Guillain-Barré syndrome is infrequent among recipients of the BNT162b2 mRNA COVID-19 vaccine

길랭-바레 증후군은 BNT162b2 mRNA COVID-19 백신의 수혜자 사이에서 드뭅니다

Observational Study

Published on 2021-09-012022-09-11
Journal: Clinical immunology (Orlando, Fla.) [Category] SARS, 임상, 치료기술,

Understanding perception and acceptance of Sinopharm vaccine and vaccination against COVID–19 in the UAE

Research

Published on 2021-08-302022-10-28
Journal: BMC Public Health [Category] COVID-19, MERS, SARS,

Safety of components and platforms of COVID-19 vaccines considered for use in pregnancy: A rapid review

Article

Published on 2021-08-132023-06-14
Journal: Vaccine [Category] MERS, SARS, 신종인플루엔자,

[키워드] adjuvant COVID-19 Pregnancy systematic review vaccine safety
[DOI] 10.1016/j.vaccine.2021.08.034 PMC 바로가기 [Article Type] Article

Disproportionality analysis of reported drug adverse events to assess a potential safety signal for pentavalent vaccine in 2019 in El Salvador

2019년 엘살바도르에서 오가나 백신의 잠재적 안전 신호를 평가하기 위한 보고된 약물 부작용 사건의 불균형 분석

Article

Published on 2021-08-092024-08-18
Journal: Vaccine [Category] 백일해, 파상풍,

[키워드] Adverse events following immunization El Salvador febrile seizure pentavalent vaccine pharmacovigilance vaccine safety
[DOI] 10.1016/j.vaccine.2021.07.010

From program suspension to the pandemic: A qualitative examination of Australia’s vaccine pharmacovigilance system over 10 years

Article

Published on 2021-08-082023-06-16
Journal: Vaccine [Category] MERS, SARS,

[키워드] Active surveillance COVID-19 vaccines pharmacovigilance qualitative research vaccine safety
[DOI] 10.1016/j.vaccine.2021.07.059 PMC 바로가기 [Article Type] Article

Motivation to COVID-19 Vaccination and Reasons for Hesitancy in Employees of a Czech Tertiary Care Hospital: A Cross-Sectional Survey

Article

Published on 2021-08-052022-10-28
Journal: Vaccines [Category] COVID-19,

With Great Hopes Come Great Expectations: Access and Adoption Issues Associated With COVID-19 Vaccines

Viewpoint

Published on 2021-08-042022-10-31
Journal: JMIR Public Health and Surveillance [Category] COVID-19, MERS,

The COVID-19 vaccine development: A pandemic paradigm

COVID-19 백신 개발: 팬데믹 패러다임

Review

Published on 2021-08-012022-09-11
Journal: Virus research [Category] MERS, SARS, 변종, 유전자 메커니즘, 진단,

[키워드] acute respiratory syndrome Antibody-dependent enhancement approved boost clinical trial clinical trials Combination coronavirus country COVID-19 COVID-19 vaccine COVID-19 vaccine development death develop disease distribution Effect effort Emergency Emergency use epidemiological Evidence evidence of feasible followed by human population human populations immune immune response immune responses immunization immunize include initiate logistics molecular Neutralizing antibodies nine nucleic acid outcome overcome pandemic paradigm phase 3 results platform predict Protein reduce Regulatory Authorities regulatory authority respiratory SARS-CoV-2 Severe acute respiratory syndrome Trial Vaccine Vaccine design Vaccine development vaccine safety Vaccine strategies. Vaccine-resistant variants variants of SARS-CoV-2 Viral
[DOI] 10.1016/j.virusres.2021.198454 PMC 바로가기 [Article Type] Review